SG Americas Securities, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$1,631,000
-44.5%
10,786
-46.6%
0.02%
-35.5%
Q2 2022$2,941,000
+116.2%
20,182
+76.0%
0.03%
+210.0%
Q1 2022$1,360,000
-49.9%
11,468
-41.7%
0.01%
-33.3%
Q4 2021$2,712,000
-2.4%
19,678
-1.7%
0.02%
+15.4%
Q3 2021$2,780,000
+207.9%
20,014
+115.1%
0.01%
+225.0%
Q2 2021$903,000
+49.5%
9,305
+5.3%
0.00%
+33.3%
Q1 2021$604,000
-33.8%
8,833
-17.1%
0.00%
-40.0%
Q4 2020$913,000
+0.4%
10,656
-23.8%
0.01%
-16.7%
Q3 2020$909,000
+60.9%
13,983
+80.9%
0.01%
+20.0%
Q2 2020$565,000
-44.3%
7,731
-74.1%
0.01%
-50.0%
Q1 2020$1,015,000
+732.0%
29,828
+1236.4%
0.01%
+900.0%
Q4 2019$122,000
-78.8%
2,232
-80.1%
0.00%
-80.0%
Q1 2019$576,000
+13.6%
11,196
-18.3%
0.01%
+25.0%
Q4 2018$507,000
+165.4%
13,697
+183.8%
0.00%
+100.0%
Q2 2018$191,0004,8260.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2020
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$107,867,00052.60%
Knoll Capital Management, LLC 856,844$83,182,00043.44%
ORACLE INVESTMENT MANAGEMENT INC 2,082,555$202,174,00027.86%
ARS Investment Partners, LLC 558,286$54,198,0005.52%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$17,113,0004.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 401,006$38,930,0004.51%
Eventide Asset Management 1,990,797$193,267,0002.60%
SILVERARC CAPITAL MANAGEMENT, LLC 56,626$5,497,0002.45%
Avidity Partners Management LP 882,500$85,673,0002.32%
Nicholas Investment Partners, LP 363,708$35,309,0002.22%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders